Lin Tami Yu-Yu, Liu Kelly Yi Ping, Novack Rachel, Mattu Pushwant S, Ng Tony L, Hoang Lynn N, Prisman Eitan, Poh Catherine F, Ko Yen Chen Kevin
Department of Anatomical Pathology, Vancouver General Hospital, Vancouver, BC, Canada; Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Department of Oral Medical Biological Sciences, Faculty of Dentistry, University of British Columbia, Vancouver, British Columbia, Canada; Department of Integrative Oncology, BC Cancer, Vancouver, British Columbia, Canada; School of Biomedical Engineering, Faculty of Applied Science and Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Mod Pathol. 2024 Dec;37(12):100614. doi: 10.1016/j.modpat.2024.100614. Epub 2024 Sep 10.
Most (60%-80%) of the oral cavity invasive squamous cell carcinoma (OSCC) demonstrate molecular alterations in TP53. The presence of TP53 mutations in multiple organ systems has been associated with a more aggressive clinical course. This study aimed to classify OSCC into p53 wild-type OSCC and p53-abnormal OSCC using p53 immunohistochemistry and to determine if abnormal p53 status correlates with a higher risk of lymph node metastasis at the time of surgery. A total of 101 patients with OSCC resection and cervical lymph node dissection were identified. p53 immunohistochemistry was performed for all cases and scored into p53 wild-type (p53-HPV: midepithelial/basal sparing, markedly reduced [null-like]/basal sparing; p53-conventional: scattered basal, patchy basal/parabasal) and p53-abnormal (overexpression basal/parabasal only, overexpression basal/parabasal to diffuse, null, and cytoplasmic) patterns. p16 immunohistochemistry and high-risk HPV RNA in situ hybridization were used to confirm the HPV status in cases showing midepithelial/basal sparing or markedly reduced (null-like)/basal sparing pattern. Logistic regression analysis was performed to investigate the association of p53 status, tumor size, depth of invasion, and pT stage against lymph node status. We identified 22 cases with p53 wild-type patterns (16 p53-conventional, 6 p53-HPV) and 79 cases with p53-abnormal patterns. Two of 22 p53 wild-type cases had positive lymph nodes (1 p53-conventional, 1 p53-HPV), whereas 40 of 79 p53-abnormal cases had positive lymph nodes (P < .001). Multivariate analysis showed that p53-abnormal pattern was an independent risk factor associated with positive node(s) with an odds ratio of 8.12 (95% CI, 2.10-53.78; P = .008). p53-Abnormal OSCCs were significantly more likely to be associated with positive lymph node status than p53 wild-type OSCCs at the time of surgery. Further investigation with long-term follow-up is required to determine its clinical application before surgery planning.
大多数(60%-80%)口腔浸润性鳞状细胞癌(OSCC)表现出TP53的分子改变。多个器官系统中存在TP53突变与更具侵袭性的临床病程相关。本研究旨在使用p53免疫组织化学将OSCC分为p53野生型OSCC和p53异常型OSCC,并确定p53异常状态是否与手术时更高的淋巴结转移风险相关。共确定了101例行OSCC切除术和颈部淋巴结清扫术的患者。对所有病例进行p53免疫组织化学检测,并分为p53野生型(p53-HPV:中层/基底保留,明显减少[类无表达]/基底保留;p53传统型:散在基底、斑片状基底/副基底)和p53异常型(仅基底/副基底过表达、基底/副基底过表达至弥漫性、无表达和细胞质表达)模式。在显示中层/基底保留或明显减少(类无表达)/基底保留模式的病例中,使用p16免疫组织化学和高危型HPV RNA原位杂交来确认HPV状态。进行逻辑回归分析以研究p53状态、肿瘤大小、浸润深度和pT分期与淋巴结状态之间的关联。我们确定了22例p53野生型模式的病例(16例p53传统型,6例p53-HPV)和79例p53异常型模式的病例。22例p53野生型病例中有2例淋巴结阳性(1例p53传统型,1例p53-HPV),而79例p53异常型病例中有40例淋巴结阳性(P<0.001)。多变量分析显示,p53异常型模式是与淋巴结阳性相关的独立危险因素,比值比为8.12(95%CI,2.10-53.78;P=0.008)。在手术时,p53异常型OSCC比p53野生型OSCC更有可能与淋巴结阳性状态相关。在手术规划前,需要进行长期随访的进一步研究以确定其临床应用价值。